Luforbec inhaler

Luforbec is a prescription pharmaceutical product used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a pressurized metered-dose inhaler containing a combination of beclometasone dipropionate and formoterol fumarate dihydrate. The brand is associated with Chiesi Farmaceutici, an international research-focused pharmaceutical group based in Italy.

While the brand belongs to an Italian company, manufacturing often takes place at Chiesi's specialized facilities, notably in Parma, Italy, which serves as a central hub for their respiratory product line. Ownership remains with the founding Chiesi family, maintaining the company's status as a private, family-owned entity with a global reach.